Cargando…

How dysregulation of the immune system promotes diabetes mellitus and cardiovascular risk complications

Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin resistance or failure to produce insulin. Patients with DM develop microvascular complications that include chronic kidney disease and retinopathy, and macrovascular complications that mai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Girard, Diane, Vandiedonck, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556991/ https://www.ncbi.nlm.nih.gov/pubmed/36247456 http://dx.doi.org/10.3389/fcvm.2022.991716

Ejemplares similares

Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses
por: Wu, Hao, et al.
Publicado: (2022)

Cardiovascular Disease Risk Factors: Hypertension, Diabetes Mellitus and Obesity among Tabuk Citizens in Saudi Arabia
por: Gutierrez, Jeneth, et al.
Publicado: (2018)

The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus
por: Xu, Shuai, et al.
Publicado: (2022)

Predictive Value of the Systemic Immune-Inflammation Index for Intravenous Immunoglobulin Resistance and Cardiovascular Complications in Kawasaki Disease
por: Liu, Xiaoliang, et al.
Publicado: (2021)

Proteomics and bioinformatics analysis of cardiovascular related proteins in offspring exposed to gestational diabetes mellitus
por: Pan, Hai-Tao, et al.
Publicado: (2022)

Assessing the performance of genetic risk score for stratifying risk of post-sepsis cardiovascular complications
por: McElligott, Brian, et al.
Publicado: (2023)

Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression
por: He, Bin, et al.
Publicado: (2022)

Comorbidity of Type 2 Diabetes Mellitus and Depression: Clinical Evidence and Rationale for the Exacerbation of Cardiovascular Disease
por: Zhu, Mengmeng, et al.
Publicado: (2022)

Related Risk Factors and Treatment Management of Psoriatic Arthritis Complicated With Cardiovascular Disease
por: Zheng, Zhoulan, et al.
Publicado: (2022)

Cardiovascular Complications of COVID-19 Vaccines
por: Liu, Runyu, et al.
Publicado: (2022)

Development of Prediction Model to Estimate the Risk of Heart Failure in Diabetes Mellitus
por: Qu, Hongling, et al.
Publicado: (2022)

Diabetes mellitus in peripheral artery disease: Beyond a risk factor
por: Singh, Madhu V., et al.
Publicado: (2023)

Association between diabetes mellitus and the risk for major cardiovascular outcomes and all-cause mortality in women compared with men: a meta-analysis of prospective cohort studies
por: Wang, Hao, et al.
Publicado: (2019)

Assessing the consequences of gestational diabetes mellitus on offspring’s cardiovascular health: MySweetHeart Cohort study protocol, Switzerland
por: Di Bernardo, Stefano, et al.
Publicado: (2017)

Systematic Understanding of Pathophysiological Mechanisms of Oxidative Stress-Related Conditions—Diabetes Mellitus, Cardiovascular Diseases, and Ischemia–Reperfusion Injury
por: Wang, Mengxue, et al.
Publicado: (2021)

Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors
por: Torrente, María, et al.
Publicado: (2022)

Validity of regional network systems on reperfusion therapy in diabetes mellitus and non-diabetes mellitus patients with ST-segment elevation myocardial infarction
por: Li, Xicong, et al.
Publicado: (2022)

Prediction and Risk Stratification of Cardiovascular Disease in Diabetic Kidney Disease Patients
por: Ren, Jingjing, et al.
Publicado: (2022)

Prevalence and Predictors of Left Ventricular Diastolic Dysfunction in Malaysian Patients With Type 2 Diabetes Mellitus Without Prior Known Cardiovascular Disease
por: Chee, Kok Han, et al.
Publicado: (2021)

Editorial: Insights in cardiovascular therapeutics 2022—cardiovascular innate immunity
por: Xu, Keman, et al.
Publicado: (2023)

COVID-19: The Cause of the Manifested Cardiovascular Complications During the Pandemic
por: Bandopadhyay, Audditiya, et al.
Publicado: (2021)

The Predictive Value of Carotid Ultrasonography With Cardiovascular Risk Factors—A “SPIDER” Promoting Atherosclerosis
por: Li, Hongwei, et al.
Publicado: (2021)

COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Increasing use of systems science in cardiovascular disease prevention to understand how to address geographic health disparities in communities with a disproportionate burden of risk
por: Bauer, Kyla L., et al.
Publicado: (2023)

A Protocol for Nurse-Practitioner Led Cardiovascular Follow-Up After Pregnancy Complications in a Socioeconomically Disadvantaged Population
por: Aldridge, Emily, et al.
Publicado: (2020)

Physical Exercise in Managing Takayasu Arteritis Patients Complicated With Cardiovascular Diseases
por: Zhou, Yaxin, et al.
Publicado: (2021)

Cardiac Complications in Immune Checkpoint Inhibition Therapy
por: Tajiri, Kazuko, et al.
Publicado: (2019)

Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors
por: Yang, Ying, et al.
Publicado: (2022)

The impact of socioeconomic deprivation on the risk of atrial fibrillation in patients with diabetes mellitus: A nationwide population-based study
por: Han, Minju, et al.
Publicado: (2022)

Editorial: Cardioimmunology: Inflammation and Immunity in Cardiovascular Disease
por: Lazzerini, Pietro Enea, et al.
Publicado: (2019)

Editorial: Immune and autoimmune mechanisms in cardiovascular disease
por: Winkels, Holger, et al.
Publicado: (2023)

SGLT2 Inhibitors in Diabetic Patients With Cardiovascular Disease or at High Cardiovascular Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhao, Zinan, et al.
Publicado: (2022)

Association between FIB-4, all-cause mortality, cardiovascular mortality, and cardiovascular disease risk among diabetic individuals: NHANES 1999–2008
por: Guan, Lihua, et al.
Publicado: (2023)

The role of post-translational modifications in driving abnormal cardiovascular complications at high altitude
por: Hou, Jun, et al.
Publicado: (2022)

Intracoronary artery retrograde thrombolysis combined with percutaneous coronary interventions for ST-segment elevation myocardial infarction complicated with diabetes mellitus: A case report and literature review
por: Shen, Mingzhi, et al.
Publicado: (2022)

Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes
por: Kanter, Jenny E., et al.
Publicado: (2020)

Cardiovascular health and potential cardiovascular risk factors in young athletes
por: Grabitz, Carl, et al.
Publicado: (2023)

GRB10 rs1800504 Polymorphism Is Associated With the Risk of Coronary Heart Disease in Patients With Type 2 Diabetes Mellitus
por: Yang, Yang, et al.
Publicado: (2021)

Diabetes Mellitus Is an Independent Risk Factor for a Stiff Left Atrial Physiology After Catheter Ablation for Atrial Fibrillation
por: Kim, Moon-Hyun, et al.
Publicado: (2022)

Association of Agriculture Occupational Exposure With Diabetes and Cardiovascular Risk Factors in South Indian Villages: REDSI Study
por: Velmurugan, Ganesan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u5t4gbca6e3siqfv5e89c6dtv1